Tinnitus Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com

Share Article

RnRMarketResearch.com adds “Tinnitus - Pipeline Review, H1 2015” to its store. The report provides an overview of the Tinnitus’s therapeutic pipeline.

Tinnitus Therapeutic Pipeline Industry

Tinnitus Therapeutic Pipeline Industry

Past News Releases

RSS

The report “Tinnitus – Pipeline Review, H1 2015” provides comparative analysis on the therapeutic development for Tinnitus. Tinnitus is the medical term for "hearing" noises in your ears when there is no outside source of the sounds. It can make verbal communication impossible and can cause depression. Depending on the type of tinnitus, symptoms will tend to come and go over time. Stress level, diet, and exposure to noise can worsen tinnitus. The report strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Complete report with TOC is available @ http://www.rnrmarketresearch.com/tinnitus-pipeline-review-h1-2015-market-report.html .

The report also reviews key players involved in the therapeutic development for Tinnitus and special features on late-stage and discontinued projects. Companies discussed in this Tinnitus – Pipeline Review, H1 2015 report include AudioCure Pharma GmbH, Auris Medical Holding AG, Flexion Therapeutics, Inc., Knopp Biosciences LLC, Merz Pharma GmbH & Co. KgaA, Otonomy, Inc., Sound Pharmaceuticals, Inc. and Synphora AB.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Drug Profiles mentioned in this report are acamprosate, AM-102, AUT-00063, AUT-3, Drug to Activate KCNQ for Tinnitus, esketamine hydrochloride, gacyclidine SR, latanoprost, neramexane mesylate, Small Molecules for Tinnitus, Small Molecules to Activate Kv7 for Neuropathic Pain, Epilepsy and Tinnitus and SPI-1005. Order a purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=314348 . (This is a premium report priced at US$2000 for a single user License.)

List of Tables
Number of Products under Development for Tinnitus, H1 2015 8
Number of Products under Development for Tinnitus - Comparative Analysis, H1 2015 9
Number of Products under Development by Companies, H1 2015 10
Number of Products under Investigation by Universities/Institutes, H1 2015 11
Comparative Analysis by Late Stage Development, H1 2015 12
Comparative Analysis by Clinical Stage Development, H1 2015 13
Comparative Analysis by Early Stage Development, H1 2015 14
Products under Development by Companies, H1 2015 15
Products under Investigation by Universities/Institutes, H1 2015 16
Tinnitus - Pipeline by AudioCure Pharma GmbH, H1 2015 17
Tinnitus - Pipeline by Auris Medical Holding AG, H1 2015 18
Tinnitus - Pipeline by Flexion Therapeutics, Inc., H1 2015 19
Tinnitus - Pipeline by Knopp Biosciences LLC, H1 2015 20
Tinnitus - Pipeline by Merz Pharma GmbH & Co. KgaA, H1 2015 21
Tinnitus - Pipeline by Otonomy, Inc., H1 2015 22
Tinnitus - Pipeline by Sound Pharmaceuticals, Inc., H1 2015 23
Tinnitus - Pipeline by Synphora AB, H1 2015 24
Assessment by Monotherapy Products, H1 2015 25
Number of Products by Stage and Target, H1 2015 27
Number of Products by Stage and Mechanism of Action, H1 2015 29
Number of Products by Stage and Route of Administration, H1 2015 31
Number of Products by Stage and Molecule Type, H1 2015 32
Tinnitus Therapeutics - Recent Pipeline Updates, H1 2015 50
Tinnitus - Dormant Projects, H1 2015 54

List of Figures
Number of Products under Development for Tinnitus, H1 2015 8
Number of Products under Development for Tinnitus - Comparative Analysis, H1 2015 9
Number of Products under Development by Companies, H1 2015 10
Comparative Analysis by Early Stage Products, H1 2015 14
Assessment by Monotherapy Products, H1 2015 25
Number of Products by Top 10 Targets, H1 2015 26
Number of Products by Stage and Top 10 Targets, H1 2015 27
Number of Products by Top 10 Mechanism of Actions, H1 2015 28
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015 28
Number of Products by Top 10 Routes of Administration, H1 2015 30
Number of Products by Stage and Top 10 Routes of Administration, H1 2015 30
Number of Products by Stage and Top 10 Molecule Types, H1 2015 32

Explore more reports on ENT Therapeutics industry at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/ent-therapeutics .

About Us:
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Ritesh Tiwari
@RnRMR
since: 06/2012
Follow >
RnR Market Research
Like >
Follow us on
Visit website